Treat EGFR mutated Non small cell lung cancer with Moboxen 40mg Capsule

Treat EGFR mutated Non small cell lung cancer with Moboxen 40mg Capsule

$9,999

It is a prescription based anticancer medicine. It comprises Mobocertinib, a tyrosine kinase inhibitor. Moboxen 40mg Capsule used to treat Non small cell lung cancer (NSCLC) with specific EFGR gene mutation. It effectively controls the spread of cancer. Always take it under strict medical supervision. Must visits the site of Globans Pharma to know the price details.

Location

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *